Genomic Evaluation of Head and Neck Cancer

Giovana Thomas, Yelizaveta Shnayder

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

This chapter summarizes recent advances in the pathogenesis, diagnosis, monitoring, prognosis, and treatment of head and neck cancer obtained by using modern molecular biological tools to study gene expression and chromosomal aberrations. Head and neck squamous cell carcinoma (HNSCC) of the upper aerodigestive tract represent approximately 4% of all cancers. Despite treatments that consist of mutilating surgery, radiotherapy, and/or chemotherapy, overall long-term survival remains low due to uncontrollable persistent or recurrent HNSCC. The low rate of survival of patients with locoregional and distant recurrences has highlighted the need for new approaches for diagnosis and treatment. The predominant environmental risk factors for developing HNSCC are the use of alcohol and tobacco, immunosuppression, chewing betel quid nuts, and exposure to high-risk human papilloma virus. Visual inspection is the most common method of detecting oral and oropharyngeal squamous carcinoma. The diagnosis is frequently delayed because symptoms for which patients seeks medical attention such as pain, dysphagia, and shortness of breath occur late in the stage of disease. Patients treated for HNSCC are followed clinically for evidence of recurrent disease and development of second primary lesions or distant metastasis. Genomic technologies have the potential to change the basis of clinical oncologic practice in various ways. © 2010

Original languageEnglish
Title of host publicationEssentials of Genomic and Personalized Medicine
PublisherElsevier Inc.
Pages511-521
Number of pages11
ISBN (Print)9780123749345
DOIs
StatePublished - Dec 1 2010

Fingerprint

Head and Neck Neoplasms
Papillomaviridae
Areca
Mastication
Chemotherapy
Tobacco
Radiotherapy
Tobacco Use
Deglutition Disorders
Aberrations
Viruses
Gene expression
Chromosome Aberrations
Dyspnea
Immunosuppression
Surgery
Squamous Cell Carcinoma
Therapeutics
Survival Rate
Inspection

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Thomas, G., & Shnayder, Y. (2010). Genomic Evaluation of Head and Neck Cancer. In Essentials of Genomic and Personalized Medicine (pp. 511-521). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-374934-5.00040-4

Genomic Evaluation of Head and Neck Cancer. / Thomas, Giovana; Shnayder, Yelizaveta.

Essentials of Genomic and Personalized Medicine. Elsevier Inc., 2010. p. 511-521.

Research output: Chapter in Book/Report/Conference proceedingChapter

Thomas, G & Shnayder, Y 2010, Genomic Evaluation of Head and Neck Cancer. in Essentials of Genomic and Personalized Medicine. Elsevier Inc., pp. 511-521. https://doi.org/10.1016/B978-0-12-374934-5.00040-4
Thomas G, Shnayder Y. Genomic Evaluation of Head and Neck Cancer. In Essentials of Genomic and Personalized Medicine. Elsevier Inc. 2010. p. 511-521 https://doi.org/10.1016/B978-0-12-374934-5.00040-4
Thomas, Giovana ; Shnayder, Yelizaveta. / Genomic Evaluation of Head and Neck Cancer. Essentials of Genomic and Personalized Medicine. Elsevier Inc., 2010. pp. 511-521
@inbook{4d470fcff1464c20b4669d3f8fc175bc,
title = "Genomic Evaluation of Head and Neck Cancer",
abstract = "This chapter summarizes recent advances in the pathogenesis, diagnosis, monitoring, prognosis, and treatment of head and neck cancer obtained by using modern molecular biological tools to study gene expression and chromosomal aberrations. Head and neck squamous cell carcinoma (HNSCC) of the upper aerodigestive tract represent approximately 4{\%} of all cancers. Despite treatments that consist of mutilating surgery, radiotherapy, and/or chemotherapy, overall long-term survival remains low due to uncontrollable persistent or recurrent HNSCC. The low rate of survival of patients with locoregional and distant recurrences has highlighted the need for new approaches for diagnosis and treatment. The predominant environmental risk factors for developing HNSCC are the use of alcohol and tobacco, immunosuppression, chewing betel quid nuts, and exposure to high-risk human papilloma virus. Visual inspection is the most common method of detecting oral and oropharyngeal squamous carcinoma. The diagnosis is frequently delayed because symptoms for which patients seeks medical attention such as pain, dysphagia, and shortness of breath occur late in the stage of disease. Patients treated for HNSCC are followed clinically for evidence of recurrent disease and development of second primary lesions or distant metastasis. Genomic technologies have the potential to change the basis of clinical oncologic practice in various ways. {\circledC} 2010",
author = "Giovana Thomas and Yelizaveta Shnayder",
year = "2010",
month = "12",
day = "1",
doi = "10.1016/B978-0-12-374934-5.00040-4",
language = "English",
isbn = "9780123749345",
pages = "511--521",
booktitle = "Essentials of Genomic and Personalized Medicine",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Genomic Evaluation of Head and Neck Cancer

AU - Thomas, Giovana

AU - Shnayder, Yelizaveta

PY - 2010/12/1

Y1 - 2010/12/1

N2 - This chapter summarizes recent advances in the pathogenesis, diagnosis, monitoring, prognosis, and treatment of head and neck cancer obtained by using modern molecular biological tools to study gene expression and chromosomal aberrations. Head and neck squamous cell carcinoma (HNSCC) of the upper aerodigestive tract represent approximately 4% of all cancers. Despite treatments that consist of mutilating surgery, radiotherapy, and/or chemotherapy, overall long-term survival remains low due to uncontrollable persistent or recurrent HNSCC. The low rate of survival of patients with locoregional and distant recurrences has highlighted the need for new approaches for diagnosis and treatment. The predominant environmental risk factors for developing HNSCC are the use of alcohol and tobacco, immunosuppression, chewing betel quid nuts, and exposure to high-risk human papilloma virus. Visual inspection is the most common method of detecting oral and oropharyngeal squamous carcinoma. The diagnosis is frequently delayed because symptoms for which patients seeks medical attention such as pain, dysphagia, and shortness of breath occur late in the stage of disease. Patients treated for HNSCC are followed clinically for evidence of recurrent disease and development of second primary lesions or distant metastasis. Genomic technologies have the potential to change the basis of clinical oncologic practice in various ways. © 2010

AB - This chapter summarizes recent advances in the pathogenesis, diagnosis, monitoring, prognosis, and treatment of head and neck cancer obtained by using modern molecular biological tools to study gene expression and chromosomal aberrations. Head and neck squamous cell carcinoma (HNSCC) of the upper aerodigestive tract represent approximately 4% of all cancers. Despite treatments that consist of mutilating surgery, radiotherapy, and/or chemotherapy, overall long-term survival remains low due to uncontrollable persistent or recurrent HNSCC. The low rate of survival of patients with locoregional and distant recurrences has highlighted the need for new approaches for diagnosis and treatment. The predominant environmental risk factors for developing HNSCC are the use of alcohol and tobacco, immunosuppression, chewing betel quid nuts, and exposure to high-risk human papilloma virus. Visual inspection is the most common method of detecting oral and oropharyngeal squamous carcinoma. The diagnosis is frequently delayed because symptoms for which patients seeks medical attention such as pain, dysphagia, and shortness of breath occur late in the stage of disease. Patients treated for HNSCC are followed clinically for evidence of recurrent disease and development of second primary lesions or distant metastasis. Genomic technologies have the potential to change the basis of clinical oncologic practice in various ways. © 2010

UR - http://www.scopus.com/inward/record.url?scp=83455227673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83455227673&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-374934-5.00040-4

DO - 10.1016/B978-0-12-374934-5.00040-4

M3 - Chapter

SN - 9780123749345

SP - 511

EP - 521

BT - Essentials of Genomic and Personalized Medicine

PB - Elsevier Inc.

ER -